Introduction
Fluid homeostasis in humans is tightly regulated under physiological conditions. Alterations of fluid volume and electrolyte balances can have multiple deleterious effects. In this review, we integrate old and new knowledge with in-depth evaluation of the effects of fluid therapy on renal hemodynamics and potential injury to the kidney.
Fluid Physiology
The human body is comprised of approximately 60% water, which is distributed one-third (20%) to extracellular and two-thirds (40%) to intracellular spaces. The extracellular fluids (ECF) are further distributed to interstitial and intravascular spaces, 80 and 20%, respectively. Thus, a 70 kg adult is comprised of ∼ 42 kg (liters) body water, 28 liters intracellular fluids and 14 liters ECF. The latter is further distributed to 11 liters interstitial fluids and ∼3 liters plasma. Electrolyte and acid-base regulations in each compartment are highly regulated, mostly in an energy-dependent manner, and have a narrow physiological window. Under physiological conditions, albumin leaks out of circulation through capillary pores at a rate of approximately 5% per hour and returns to the circulation via the lymphatic system and the thoracic duct [1] . Extensive and dynamic exchanges exist between the ECF and gastrointestinal system as well as the kidneys. There is a turnover of 8-9 liters/day of gastrointestinal fluids (secretion and absorption) [2] and 180 liters/day of glomerular filtrates of which 98-99% is absorbed by renal tubules. Multiple factors, including a large number of medications, could affect these balances.
Vascular Fluid Homeostasis
Tissue health is dependent on adequate oxygenation. Tissue oxygenation is the main function of the microcirculation. Over the years, the concept of microcirculation originated by Ernest Starling (classic Starling principle) in 1896 [3] has been challenged by a number of new discoveries, and a revised Starling principle emerged [4] .
The classic Starling principle (1896) proposes that transport of fluids to and from the interstitial space of peripheral tissues is balanced between opposing oncotic and hydrostatic forces (pressure) across the vessel wall ( fig. 1 a, b) [3] . Emerging evidence does not support this concept. The classic principle was called into question by the discovery, both by imaging and by functional studies [5] [6] [7] [8] , of a negatively charged, gel-like glycocalyx layer (when binding with plasma constituents, it is also known as the endothelial surface layer, ESL), covering the surface of the endothelium ( fig. 1 c) . ESL was shown to be present throughout the vasculature but was more prominent in vessels with a higher magnitude of hydrostatic pressure [9] . The first recognition of substantial contribution of the endothelial glycocalyx, the ESL, to the vascular barrier dates back to the early 1980s [10] . Levick famously noted 'low lymph flow paradox', in that vascular barrier remains competent even when the interstitial oncotic pressure equals that in vascular lumen [11, 12] . Studies have also demonstrated that the oncotic gradient between the vessel lumen and interstitium is, in fact, minimal and would not account for any gradient-driven inward fluid shift [13, 14] . Movement of fluids into the interstitial space is largely prevented by the opposing oncotic and hydrostatic pressures within vascular lumen at the level of ESL, not across the vessel wall [12] . It has become clear that the ESL plays a pivotal role in preventing excessive vascular fluids extravasation, thus preventing the formation of tissue edema. Indeed, there has been no evidence showing that interstitial fluids can be reabsorbed into the venular site of the vessel through oncotic pressure gradient [15] . More than a major regulator of the plasma fluid filtration [4, 16] , the ESL has proven to be important in providing vascular protection [17] and regulation of microvascular blood flow [18, 19] . It mediates sheer stress from the blood flow through the endothelial cells [20] and prevents leukocyte-endothelium and platelet-endothelial adhesion [21] .
The endothelial glycocalyx consists primarily of membrane bond glycoproteins (adhesion molecules, selectin and integrins) and proteoglycans (syndecans and glypicans and side chains containing heparin and chondroitin sulphates) [7] . ESL has a functional thickness of about 1 μm (reviewed in [6, 19] ). General consensus is that its width varies in different regions of vasculature. Large vessels show thicker/wider ESL than those in microvessels [9] . The relative contributions of the major GAGs to the thickness of the ESL and to its small solute permeability have been demonstrated in rodent mesenteric vessels [22] . There is a dynamic equilibrium between the proteins in the blood stream and those bound to the ESL [6, 23] . A small space of <100 nm beneath the ESL is almost protein free, and this generates an oncotic pressure gradient to deter the passage of protein outward (inwardly directed oncotic gradient) within the vessel lumen [13] . The ESL also lowers hydraulic conductivity (fluid filtration rate/area/pressure gradient), thus retarding hydrostatic pressure-mediated fluids extravasation [24] .
The ESL can be compromised during ischemia-reperfusion injury, sepsis, inflammation, hypervolemia, diabetes and oxidized lipids [25] [26] [27] [28] [29] [30] [31] . Inflammation increases the permeability of the endothelial glycocalyx layer to polyionic macromolecules allowing fluids to move into the interstitium [32] [33] [34] . Volume expansion triggers the production of atrial natriuretic peptides (ANP) from the atrium. ANP is capable of effectively degrading endothelial glycocalx, leading to ESL injury and barrier failure [25, 35] . Maintenance requirement for water in adults under physiological condition is 25-35 ml/kg/day. Daily requirements of sodium (Na) and potassium (K) are approximately 1 mmol/kg/day. The kidneys are endowed with an impressive capacity to conserve Na. They are, however, woefully unprepared to deal with the opposite, Na excess. Thus, humans cope with low Na intake much better than high Na intake. Such a trait is hereditary and is a result of millions of years of terrestrial evolution in which humans, in response to the Paleolithic (low salt) diet [36] , have adapted physiologically and metabolically to retain Na. It is not surprising that overabundance of Na intake, which has occurred in the last decades, has been linked to the genesis of a number of serious and chronic diseases, including hypertension and cardiovascular diseases [37, 38] . Similarly, overuse of crystalloid infusion in hospital has resulted in multiple complications including mortality, and this finding has been summarized and confirmed in a recent study [39] .
Fluid administration is the most common intervention prescribed to hospitalized patients. Improper fluid prescription can cause multiple adverse effects and contribute to patients' mortality [40] . Whether or not to administer the intravenous fluids should be based on clinical settings. If the patient is hemodynamically stable and is made NPO for <8 h for an elective procedure, no maintenance fluids are required [41] . In patients postabdominal open surgery, even fluid balance postoperatively over the course of up to 5 postoperative days is important to a better clinical outcome compared to those with fluid imbalance, mostly with a net positive balance [40] .
For patients with complicated cardiovascular surgery such as open repair of abdominal aortic aneurysms and cardiac valve replacement, postoperative vasoplegia is common, largely related to extensive tissue injury and damage-dependent molecular patterns [42] . Treatment requires a combination of isotonic fluids and vasoactive agents. For patients with sepsis and septic shock, fluids in combination with pressors are required especially for patients during the initial resuscitation period [43] .
If the IV fluids are deemed necessary, crystalloid fluids are, in general, preferred to colloid fluids with a few exceptions. In patients with acute hemorrhagic shock, blood products are preferred to maintain volume status and tissue perfusion. In patients with cirrhosis and advanced hepatic failure, albumin-containing fluids and, recently, albumin dialysis can be beneficial [44] . There are conditions under which colloids could be detrimental. For instance, in patients with acute brain trauma, albumincontaining fluids have been shown to increase complications, including mortality [45, 46] . Semi-synthetic colloid solutions, such as hetastarch-containing fluids, are no longer advised clinically because of multiple adverse effects, including (1) increased occurrence of kidney dysfunction, (2) greater need for blood transfusion, and (3) increased mortality in certain clinical settings [47, 48] . The detrimental effects of semi-synthetic colloids may have been related to the accumulation of low molecular weight fraction in proximal renal tubules and osmotic nephrosis [49] .
Among crystalloid fluids, balanced fluids are preferred to high chloride-containing fluids, that is, 0.9% saline. In balanced crystalloid fluids, metabolizable anions are incorporated to substitute bicarbonate and the final components of a balanced crystalloid resemble the constituents of normal plasma [50] . High chloride-containing saline, that is, 0.9% saline contains super physiological content of chloride which, when infused in large quantities (>2 liters), can cause hyperchloremic acidosis, which may engender complications including coagulopathy, hyperkalemia and more pronounced interstitial fluid retention; 0.9% saline infusion also causes greater fluid retention ( ∼ 60% by 6 h post infusion) than that of 5% dextrose in normal adults [51] . Moreover, Chowdhury et al. [52] have shown that 56% of infused saline was retained in the body 6 h after the infusion in healthy volunteers, compared to 30% retention of Hartmann's solution [53] . When 0.9% saline was compared to plasmalyte, calculated interstitial volume increased more with saline than with plasmalyte. Negative microcirculatory effects are exerted on the kidneys by 0.9% saline (detailed below).
In a few clinical scenarios, 0.9% saline is indicated. For patients with acute central nervous system events, 0.9% saline may be preferred, as it has an osmolality of 308 msOm/l, a slightly higher tonicity than that in the commonly used balanced fluids (i.e., lactated ringers). For patients with metabolic alkalosis due to upper GI diseases, gastric suction or chronic vomiting, 0.9% saline is an appropriate fluid of choice.
The goal of fluid resuscitation is to optimize hemodynamics, increase stroke volume, and ultimately improve organ perfusion and O 2 delivery. In critically ill patients, the Sepsis Campaign has advocated initial fluid resuscitation (up to 30 ml/kg) within the first 6 h of presentation [43] . After the initial resuscitation, persistent net positive fluid balance is not advised in general, as it can lead to [54] [55] [56] and should be avoided. Current measurements for fluid status are indirect and mostly less than ideal, although a recent study in critically ill patients using bioimpedance has shown initial exciting results [39] . In recent years, several direct microcirculation monitoring techniques have also been devised [57] . Although initial studies have shown some correlation between mortality and the direct microcirculation measurement in early ICU admissions ( ≤ 48 h) [58] [59] [60] , the results have not been consistent, especially in heterogeneous ICU patients [61] . Moreover, in their current state, the methods require cumbersome offline data analysis, not yet feasible for routine bedside use. These methods, nonetheless, provide hope for a better determination of the patient's microcirculatory status and tissue oxygenation to guide fluid therapy in the near future.
Kidneys are Sensitive to Fluids and Volume Status
The kidneys are sensitive to both arterial and venous flow. Insufficient arterial flow and or venous congestion can rapidly impair renal clearance. As the kidney is encapsulated and has little room to expand, venous congestion engorges the kidney, causing intracapsular pressure buildup, reducing both venous and lymphatic outflow as well as arterial blood inflow ( fig. 2 ) . Studies have shown that 30 min of ischemia by clamping the renal vein resulted in several fold higher of serum creatinine elevation than clamping of renal arteries for the same duration [62, 63] . Even in a normal individual, kidney volume increases in response to crystalloid fluid infusion [52] , indicating intra-renal fluid retention. Given the microvascular leakiness in critically ill patients, with fluid therapy, the intrarenal fluids retention and edema could be more prominent. The interstitial edema would impede forward arterial blood flow as well as venous return and lymphatic drainage, leading to an impaired tissue oxygenation, acute kidney injury (AKI) and further worsening congestion, creating a vicious cycle ( fig. 2 ) . Studies have shown that in patients with sepsis and after abdominal surgery, cumulative fluid balance is strongly associated with AKI occurrence and progression [64, 65] . Patients who received conservative fluid administration and vasopressors tend to have favorable kidney outcome and decreased odds for the development of AKI [65] . Exogenous pressure to the kidneys due to obesity and abdominal ascites can also compromise renal blood flow both in the arterioles and the venues causing anuric AKI [66] , analogous to the compartment syndrome.
Although 0.9% saline and balanced fluids can both lead to renal volume expansion, interstitial fluid retention and adverse intra-renal microvascular effects are more pronounced with 0.9% saline infusion [52, 53] . Chowdhury et al. [52] clearly show that 0.9% saline infusion (2 liters), when compared to the same amount of balanced fluid infusion, causes more significant reduction in the renal cortical blood flow and oxygen delivery. Such differences likely are related, at least in part, to the super 168 physiological chloride content in 0.9% saline, which activates the tubuloglomerular feedback among other renal tubular effects [67] , causing afferent arteriole vasoconstriction [50] . Simultaneous venous congestion and afferent arteriole constriction further diminish forward blood flow [68] . In line with these mechanisms, studies have shown that postoperative hyperchloremia in patients with normal preoperative serum chloride is associated with postoperative renal dysfunction [69] .
Chloride restrictive fluids have been associated with a lower hospital mortality and decreased incidence of AKI or need for renal replacement therapy in critically ill patients [70, 71] . Recently, a multi-center prospective study evaluating 0.9% saline vs. balanced fluids in ICU patients, however, has shown no difference in the outcome [72] . The study, however, was focused on ICU patients, and the types of IV fluids given to the study participants prior to the ICU admission were unclear. In practice, critically ill patients typically receive large amounts of fluids during transit, in the ED, and prior to the ICU admission. Thus, further IV fluids in the ICU may not be sensitive enough to detect a difference. Also, large amounts of total fluids administration, regardless of the type of fluids, can be detrimental. Further studies are needed preferably to evaluate the total amount of fluid therapy in critically ill patients with a specific time frame from their initial presentation.
The rate of IV fluids is also likely to impact kidney function. Rapid IV infusion can transiently raise atrial pressure, resulting in ANP release. The latter rapidly degrades the endothelial surface glycocalax layer [27, 30] , compromising the barrier function. Intravenous fluids can readily enter the interstitial compartment, leading to intra-renal pressure build-up and AKI. Moreover, ESL damage can also cause inflammation and microthrombosis [6, 8] , leading to sustained kidney dysfunction.
For patients who have developed AKI and are in need of fluids, the current recommendations put forth by KDIGO (kidney disease improvement global outcome) are to use isotonic crystalloids in the absence of hemorrhage [73] . AKI predisposes to fluid infusion-associated alterations in electrolytes, acid-base and in tonicity as the kidney's concentration and diluting capacities are vastly compromised. Intravenous fluids should be used with caution to avoid volume overload and interstitial congestion (Box 1). Patients with new onset proteinuria and active urine sediment (renal tubular epithelial cells) but who fail to meet the conventional sCr criteria of AKI (Box 2) should be managed carefully to optimize perfusion pressure, volume status [64] and avoidance of situations or agents that could be injurious to the kidney.
Unfortunately, in practice, providers are inclined to use albumin infusion in patients with overt fluid overload such as dependent edema and pulmonary congestion in an attempt to 'recruit interstitial fluids'. The endothelial barrier failure readily leaks infused albumin into the interstitium, resulting in an increase in the interstitial oncotic pressure and worsening interstitial edema and further diminishing O 2 in the kidneys. It is not surprising that to date, no study has shown any outcome advantage of albumin infusion over crystalloid infusion for (non-cirrhotic) critically ill patients [74, 75] .
Taken together, kidneys consume large amounts of oxygen. The PO 2 in the outer medullar is at ∼ 5-10 mm Hg under normal conditions. The kidney is thus sensitive to both insufficient and excessive fluid administration. Considering Fick's law, tissue O 2 diffusion is determined by (1) the O 2 gradient between capillary and tissue, (2) diffusional distance, and (3) area available for gas exchange [76] , reduced renal arterial flow, interstitial edema, elevated intra-capsular pressure, and renal venous congestion can work in concert to deplete intra-renal O 2 and incite inflammatory reaction, leading to persistent kidney injury.
Conclusion
Much progress has been made over the last several decades in our understanding of vascular homeostasis. Solid evidence indicates the existence of ESL and its functional significance in microcirculatory fluid homeostasis and vascular protection, including its role as a barrier of plasma fluids extravasation, sheer stress and receptormediated regulations, anti-thrombosis and anti-inflammation. The recognition of factors that can injure and compromise the ESL should caution us to be mindful in practice. Fluid management can impact ESL integrity, microcirculation and tissue O 2 supply. In the kidney, suboptimal fluid therapy, insufficient or excessive, can cause AKI and worsen existing AKI. Uncertainty and controversy remain regarding appropriate fluid management for critically ill patients including AKI patients, mainly due to the lack of reliable methods to determine patient fluid status. Recently, a new generation of handheld microscopy with automatic analysis software has generated excitement in the hope of providing a means to access vital organ microcirculatory status at the bedside in vivo and noninvasively to better guide fluid ther- 169 apy in the near future. Due to the nonavailability of reliable volume assessment tools, clinicians continue to use a variety of surrogate markers for volume determination. Emphasis should nonetheless be placed on appropriate fluid selection and judicious fluid administration to avoid alterations in volume status and electrolyte balance, especially to avoid overt volume overload, which is a known cause of AKI, multiorgan failure and mortality. Fluid management for patients with existing AKI can be challenging. The impaired capacity to produce, concentrate and dilute urine can cause severe alterations in fluid and acid-base/electrolyte balance and should be taken into consideration when prescribing fluids for AKI patients.
Box 1.
Fluid management in the setting of AKI Mr. NC is a 65-year-old man with severe ulcerative colitis and pulmonary fibrosis. He underwent a diverting loop ileostomy post total colectomy on June 28, 2016. Postoperatively, he received ketorolac both IV and oral for pain. Postoperative day 3, his serum creatinine (sCr) began to rise, from 1.1 on admission to 3.6 mg/dl on July 4, 2016. His urine output declined (to 5-15 ml/h) and, meanwhile, his ileostomy output increased from 5.5 liters on July 2 to >7 liters on July 3 and 10 and 12 liters on July 4 and 5. He was started on IV 0.9% saline initially. He developed hypernatremia, acidosis and hyperkalemia. Nephrology Service was emergently called. Saline was changed to lactated ringers overnight. Next morning, his BP was 110/74 mm Hg, HR 82/min, RR 18/min, temperature 36.5. He had basilar crackles in both lung fields (which was his baseline due to chronic lung disease). His heart and abdomen were benign. Ileostomy bag was full and liquidy. No skin rash and no dependent edema were observed. Laboratory studies revealed hemoglobin 12.1 g/dl, leukocytes 10.7 × 10 9 /liters, platelets 2,757 × 10 9 /liters, sodium 131 mmol/l, potassium 4.4 mmol/l, phosphorus 3.7 mg/dl, chloride 94 mmol/l, bicarbonate 20 mmol/l, BUN 37 mg/dl, creatinine 2.9 mg/dl. Urinalysis revealed granular casts and renal epithelial cells (4-10/hpf).
Questions:
Management of acute kidney failure and decreased urine output. Management of fluid replacement and serum electrolytes.
Answer:
This patient has a high-grade AKI likely due to a combination of hemodynamic instability during the operation and postoperative NSAID exposure. He also had a large ileostomy output that has caused additional volume fluctuation. He initially received 0.9% saline, which contributed to his hyperkalemia and acidosis. IV fluids were changed to lactated ringers overnight (as per the nephrology recommendation).
On examination next day, he was euvolemic. Nephrology Service recommended loop diuretics to promote urine output and replace the output of ileostomy and urine with 0.9% saline and lactated ringers alternating in 1:1 ratio and maintain his net fluid balance at around 0 to slightly negative (-0.5 to -1.0 l/day) as long as he was hemodynamically stable. His electrolytes gradually returned to reference range. His ileostomy output peaked at 16.9 liters on July 8 and subsequently reduced to <4 liters by July 11. His sCr reduced from a peak of 3.6 mg/dl to 0.9 mg/dl. He was discharged with oral sodium bicarbonate and sodium chloride tablets.
This case illustrates the complexity of fluid management in the setting of AKI. In general, crystalloids should be given with specific attention to the patient's tonicity, fluid balance and acid-base status. Postoperatively, the patient should be kept in an euvolemic state. Kidneys have limited capacity to excrete Na, especially post operation. Overzealous fluid prescription can lead to volume overload, especially in patients who have developed AKI. Compared to normal serum, 0.9% saline has a slightly higher osmolality, and lactated ringers slightly lower osmolality. The alternate use would cancel out the potential alteration of osmolality with the exclusive 0.9% saline or exclusive lactate ringers. The patient's urine output should also be taken into consideration when prescribing fluids. As the patient's output reduces, the replacement fluids should be tapered down accordingly.
Box 2.
Management of a patient who demonstrated new renal abnormality but failed to meet AKI criteria A 77-year-old woman with a history of hypertension on treatment for >10 years, coronary artery disease, and stage 3 CKD with sCr of 1.7 mg/dl was admitted for an acute gall stone associated pancreatitis. She underwent laproscopic cholecystectomy. During the procedure, she experienced transient episodes of hemodynamic instability with systolic BP briefly dropped to around 80 mm Hg. She received IV 0.9% saline intra and postoperatively. On post-procedure day 3, her weight was 5 kg above her admission weight, her BP was 146/88 mm Hg, HR 70/min. She developed dependent edema 1+ in the lower extremities. Serum electrolytes showed (in mmol/l) Na 142, K 5.1, Cl 107, HCO3 20, BUN 38 mg/dl, Cr 1.8 mg/dl. Urinalysis showed new 1+ protein, protein to osmolality ratio of 0.5, microscopy 1-3 renal epithelial cells/hpf. Her urine output was 700-900 ml/day for the past 2 days. Because of the abnormal sCr, she did not receive any diuretics that were in her outpatient regimen.
Question:
What would be your recommendation for this patient with urine abnormality?
Answer:
Approximately two-thirds of the patients with mild AKI progress to severe stages of AKI. AKI and its severity are directly related to patient outcome including increased requirement for renal replacement therapy, persistent kidney dysfunction with new onset CKD or worsening CKD and short-term and long-term mortality. As shown in this patient, some patients may present with evidence of kidney injury but do not fit the current definitions of AKI. In these patients, especially those with predisposing conditions for AKI such as pre-existing CKD, hypertension, coronary artery disease and diabetes with potential for experiencing kidney insult such as procedures with risks of hemodynamic instability, intravenous contrast or other nephrotoxic agents, active nephrology involvement likely can prevent or minimize kidney injury progression and alter patient outcomes. This type of patient should be monitored closely to ensure adequate perfusion pressure (arterial BP ≥65 mm Hg), optimize volume status, and avoid, if at all possible, exposure to agents that could be nephrotoxic. This patient was hypervolemic. Diuretics should thus be used to correct her volume expansion while maintaining adequate perfusion pressure.
Diuretic use in the setting of AKI and volume overload has not been shown to be nephrotoxic. This patient also has hyperchloremic acidosis. Hyperchloremic acidosis can induce afferent artery constriction (tubuloglomerular feedback, TGF), decreasing renal perfusion, decreasing urine output and can cause kidney injury. In this patient, after improving her volume status with diuretics, isotonic sodium bicarbonate could be considered to balance her acid-base status. Acidosis increases renal ammonium genesis in an attempt to unload acid via urinary ammonia excretion. In the setting of reduced urine output, renal ammonium accumulation can activate complements, endothelin and aldosterone, leading to intra-renal inflammation and worsening kidney dysfunction. Thus, acidosis should be corrected. The continued use of ACE inhibitor or ARB is controversial. There has been no randomized study comparing continuing or discontinuing ACE inhibitor and ARB in the setting of AKI. ACE inhibitor and ARB have theoretical benefits of anti-inflammatory capacity. On the other hand, by way of dilating efferent artery, they potentially induce less than optimal renal hemodynamics in the setting of early stage kidney dysfunction. In our practice, if the patient's perfusion pressure is suboptimal, we would withhold antihypertensives including ACE inhibitor and ARB. If the patient is hemodynamically stable and has been on a stable regimen of ACE inhibitor and ARB, we continue the same regimen.
• Fluid therapy should be prescribed based on the patients' clinical setting and daily requirements with a goal to restore patients to their physiological state.
• During initial resuscitation, treatment goals should include both hemodynamic stabilization and microcirculation optimization in order to maintain adequate tissue O 2 supply.
• Fluid selection can impact patient outcome; appropriate fluid should be selected to avoid alterations in serum tonicity, electrolytes and acid-base balance.
• Preservation of the glycocalyx layer should be taken into consideration when prescribing fluids.
• Interstitial volume overload is associated with AKI, multiple complications and increased mortality.
• Kidney tolerates balanced fluids better than high-chloride fluids (i.e., 0.9% saline).
• Volume overload (regardless of fluid type) raises kidney intra-capsular pressure, causing AKI, analogous to the compartment syndrome.
• Newer volume-assessment methods and direct bedside determination of tissue microcirculation hold the future for a better determination of volume status to guild fluid therapy for critically ill and AKI patients.
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